Login / Signup

Effectiveness and Safety of Sacubitril/Valsartan in Patients with Chronic Kidney Disease-A Real-World Experience.

Sara Couto PereiraTiago RodriguesAfonso Nunes-FerreiraJoão R AgostinhoFausto J PintoDulce Brito
Published in: Journal of clinical medicine (2023)
sacubitril/valsartan was effective on reducing HFH and LOS without affecting all-cause mortality in a CKD real-world population.
Keyphrases
  • ejection fraction
  • chronic kidney disease